BIO-BBIO-BNYSE
Loading
Operating Expenses Over TimeStable
Percentile Rank93
3Y CAGR+0.8%
5Y CAGR+1.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+0.8%/yr
vs +1.2%/yr prior
5Y CAGR
+1.8%/yr
Consistent
Acceleration
-0.4pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.11B | +0.1% |
| 2024 | $1.11B | +1.9% |
| 2023 | $1.09B | +0.4% |
| 2022 | $1.08B | -4.7% |
| 2021 | $1.14B | +11.9% |
| 2020 | $1.02B | -1.0% |
| 2019 | $1.03B | -0.5% |
| 2018 | $1.03B | -2.5% |
| 2017 | $1.06B | +3.6% |
| 2016 | $1.02B | - |